Sales of the ground-breaking cystic fibrosis (CF) drug Kaftrio was the main driver behind revenues of a Dublin unit of Vertex ...

CRSP edges ahead of NTLA with the only approved CRISPR therapy, stronger pipeline breadth and recent stock gains.

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.

A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes — during a ...

Analysts remain bullish on Vertex Pharmaceuticals as HC Wainwright reaffirmed its buy rating with a $550 price target.